- Investing Ideas
- /
- Top Growth Stocks
Top Australian (ASX) Growth Stocks
UPDATED Jun 29, 2022
What are the best Australian (ASX) Growth Stocks?
According to our Simply Wall St analysis these are the best Australian growth companies. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.
Our criteria to find Top Growth Companies
Growth
- Companies with sustained revenue growth that outperforms the market are attractive to investors. These companies are most likely to appreciate in share price over time.
What do we look for?
- Is the company forecast to have high earnings growth.
Healthy Balance Sheet
- A healthy balance sheet is essential to drive growth opportunities and sustain the business.
- Repayments on debt take precedence over other initiatives to improve shareholder returns, so investors want to make sure the company is comfortably positioned to cover its debts.
What do we look for?
- Does the company have a manageable level of debt.
- Is the company able to cover its interest repayments.
55 companies meet this criteria in the Australian market
Amaero International Ltd engages in the research, development, manufacture, and sale of laser-based metal additive products in Australia.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: 3DA is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 98.7% below our estimate of its fair value
Earnings are forecast to grow 119.75% per year
Risks
Has less than 1 year of cash runway
Makes less than USD$1m in revenue (A$599K)
Does not have a meaningful market cap (A$40M)
Shareholders have been diluted in the past year
Etherstack plc, a wireless technology company, engages in licensing mission critical radio technologies to equipment manufacturers and network operators Australia and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: ESK's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 45% below our estimate of its fair value
Earnings are forecast to grow 46.57% per year
Became profitable this year
Risks
High level of non-cash earnings
Does not have a meaningful market cap (A$52M)
Volatile share price over the past 3 months
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: CUV's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 32.1% below our estimate of its fair value
Earnings are forecast to grow 29.38% per year
Earnings grew by 15.2% over the past year
Risks
Significant insider selling over the past 3 months
Jervois Global Limited explores for and evaluates mineral properties in the United States, Brazil, Finland, Australia, and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: JRV is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 87% below our estimate of its fair value
Earnings are forecast to grow 59.7% per year
Risks
Has less than 1 year of cash runway
Shareholders have been substantially diluted in the past year
Polynovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: PNV's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 41.1% below our estimate of its fair value
Earnings are forecast to grow 72.36% per year
Became profitable this year
Risks
Large one-off items impacting financial results
Nickel Industries Limited engages in nickel ore mining and nickel pig iron production operations in Singapore and Indonesia.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: NIC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 61.3% below our estimate of its fair value
Earnings are forecast to grow 35.65% per year
Earnings have grown 56% per year over the past 5 years
Risks
Shareholders have been diluted in the past year
Tulla Resources Plc explores for, evaluates, and develops gold property in Australia.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: TUL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 94.5% below our estimate of its fair value
Earnings are forecast to grow 81.79% per year
Risks
Makes less than USD$1m in revenue (A$249K)
Does not have a meaningful market cap (A$136M)
Large one-off items impacting financial results
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: CGS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 62.2% below our estimate of its fair value
Earnings are forecast to grow 26.96% per year
Earnings grew by 2812.4% over the past year
Risks
Large one-off items impacting financial results